Option Care Health, Inc. (NASDAQ:OPCH) Position Boosted by US Bancorp DE

US Bancorp DE increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 5.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,199 shares of the company’s stock after buying an additional 393 shares during the quarter. US Bancorp DE’s holdings in Option Care Health were worth $287,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bessemer Group Inc. grew its holdings in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after buying an additional 599 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after buying an additional 332 shares in the last quarter. Wealthquest Corp bought a new position in Option Care Health in the 1st quarter worth approximately $66,000. Farther Finance Advisors LLC grew its holdings in Option Care Health by 434.8% in the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company’s stock worth $67,000 after buying an additional 1,561 shares in the last quarter. Finally, Johnson Financial Group Inc. bought a new position in Option Care Health in the 4th quarter worth approximately $47,000. 98.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on OPCH. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. UBS Group raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, JMP Securities boosted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $35.75.

Option Care Health Trading Down 0.4%

Shares of Option Care Health stock opened at $28.41 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The firm has a market cap of $4.61 billion, a price-to-earnings ratio of 22.73, a price-to-earnings-growth ratio of 1.80 and a beta of 0.79. The business has a fifty day simple moving average of $30.36 and a 200-day simple moving average of $31.87. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company’s revenue was up 15.4% compared to the same quarter last year. During the same period last year, the company posted $0.30 EPS. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.